Treatment of anxiety disorders in adolescents - a feasibility study for a brief cognitive therapy for adolescent anxiety disorders

niversity of Reading0 sites48 target enrollmentNovember 23, 2017

Overview

2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31023352 protocol (added 29/04/2019)

Registry

who.int

Start Date

November 23, 2017

End Date

June 4, 2019

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

niversity of Reading

•1\. Young people (aged 11\-17\.5 years at intake) whose primary presenting disorder is a DSM\-5 diagnosis of an anxiety disorder
•2\. If young people have been prescribed psychotropic medication the dosage must have been stable for two months

•1\. Young people with co\-morbid conditions that are likely to interfere with treatment delivery, to include an established autistic spectrum disorder or learning disabilities, suicidal intent or recurrent or potentially life\-limiting self\-harm (i.e., current frequency of at least once per week or self\-harm that requires medical attention)
•2\. Young people with a primary presenting disorder other than an anxiety disorder (including a DSM\-V diagnosis of major depressive disorder (MDD))
•3\. Young people identified by social services as currently ‘at risk’ due to child protection concerns